×
For best experience we recommend to activate Javascript in your browser.
IREM1 antibody (N-Term)
The Rabbit Polyclonal anti-IREM1 antibody has been validated for WB, ELISA, IHC and FACS. It is suitable to detect IREM1 in samples from Human.
Quick Overview for IREM1 antibody (N-Term) (ABIN2234984)
Target
See all IREM1 Antibodies
IREM1
(Immune Receptor Expressed On Myeloid Cells 1 (IREM1))
Reactivity
All reactivities for IREM1 antibodies
Human
Host
All hosts for IREM1 antibodies
Rabbit
Clonality
All clonalities for IREM1 antibodies
Polyclonal
Conjugate
All conjugates for IREM1 antibodies
This IREM1 antibody is un-conjugated
Application
All applications for IREM1 antibodies
Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Flow Cytometry (FACS)
Product Details anti-IREM1 Antibody
(hide)
Binding Specificity
All epitopes for IREM1 antibodies
AA 63-92, N-Term
Cross-Reactivity
Human
Cross-Reactivity (Details)
Calculated cross reactivity: Hu
Characteristics
CLM1, NT (CD300LF, CD300F, CLM1, IGSF13, IREM1, NKIR, CMRF35-like molecule 1, CD300 antigen-like family member F, Immune receptor expressed on myeloid cells 1, Immunoglobulin superfamily member 13, NK inhibitory receptor, CD300f)
Purification
Purified by Protein A affinity chromatography.
Immunogen
CLM1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 63~92 amino acids from the N-terminal region of human CLM1.
Isotype
IgG
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working conditions should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Buffer
Supplied as a liquid in PBS, pH 7.2, 0.09 % sodium azide.
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
-20 °C
Storage Comment
-20°C
Target Details for IREM1
(hide)
Target
IREM1
(Immune Receptor Expressed On Myeloid Cells 1 (IREM1))
Alternative Name
CLM1
UniProt
Q8TDQ1
Recently viewed
(hide)
Chat with us , powered by LiveChat